Skip to content
2000
Volume 18, Issue 7
  • ISSN: 1389-5575
  • E-ISSN: 1875-5607

Abstract

The serotonin system exerts its effects on the CNS and many peripheral systems. Of the 14 serotonin receptors, the 5-HT7 receptor is the most recently discovered. The 5-HT7 receptor has been shown to be involved in stress reduction, depression, and nociceptive control. Despite the 20 years since the discovery of 5-HT7R, there are still few truly selective ligands. Two of the common scaffolds for 5-HT7R ligands are long chain arylpiperazines (LCAPs) and sulfonamide containing compounds. This review focuses on recently developed (2014-2016) 5-HT7R ligands, their selectivity for the receptor, and suggests the possible new pharmacophore models for these ligands.

Loading

Article metrics loading...

/content/journals/mrmc/10.2174/1389557517666170913111533
2018-04-01
2025-09-21
Loading full text...

Full text loading...

/content/journals/mrmc/10.2174/1389557517666170913111533
Loading

  • Article Type:
    Review Article
Keyword(s): 5-HT7; Arylpiperazine; CNS; drug design; pharmacophore; serotonin
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test